Single Use Technologies (SUT) in Pharmaceutical Manufacturing
Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
Redefining RNA Manufacturing Through Innovation in Biocatalysis
Energetic Chemistry in Pharma
Rise of AI ML-Powered Accelerators in Pharma Secure Supply Chain
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
AI-Powered Clinical Trials: Accelerating Study Design and Execution
For more than a decade the industrys capital and attention have flowed toward the front of the pipeline Target identification generative chemistry and structural prediction have all been genuinely transformed Yet the median interval from firstinhuman dosing to approval has barely moved The reason is uncomfortable but well understood inside every development committee the constraint is no longer fi...
-
Techno Trends
University Researchers Develop CAR T Therapy Candidate for Solid Tumour Treatment
Researchers from the University of Calgary and McMaster University have developed a novel CAR T cell therapy approach targeting treatmentresistant solid tumours
-
Projects
BeOne Medicines Invests US$300 Million to Expand New Jersey Manufacturing Campus
BeOne Medicines has announced a US million expansion of its Princeton West Innovation Campus in Hopewell New Jersey strengthening its US manufacturing and research capabilities
-
Research Insights
Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently
Thymidylate synthase TS is a key enzyme in thymidylate biosynthesis and an established target of chemotherapeutics such as fluorodeoxyuridine FdUR and raltitrexed RTX Inhibition of TS disrupts
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Optimizing Pharma Distribution: Navigating the Supply Chain Landscape
Kate Williamson
This comprehensive article explores critical strategies employed by pharmaceutical companies to enhance the efficiency of their distribution and logistics processes. The dynamic pharmaceutical landsca...
-
2
The Translational Gap Is Killing Your Best Molecules
Lakshmi
In an era of unprecedented scientific capability, the gap between promising preclinical data and clinical reality remains one of the industry's most persistent challenges.
-
3
Applying CPCA: A Risk Based Framework for Nitrosamine Control in Pharmaceuticals
Subathra Ramamoorthy
As nitrosamine control shifts from reactive testing to a lifecycle, risk based obligation, the Carcinogenic Potency Categorization Approach (CPCA) has emerged as a critical regulatory tool. This arti...
-
4
From Qubits to Proteins: Quantum Computing's Promise in Protein Folding
Vidya Niranjan
Quantum computing's fusion with biochemistry ushers a new era of scientific exploration, offering breakthroughs in pharmaceuticals. This article explores quantum mechanics' role in protein fol...
-
5
Preclinical Development for Topical Drug Products
Dr. Om Shelke
Preclinical development of topical drug products is crucial for evaluating skin delivery, safety, and efficacy. This article explores contemporary strategies, innovative technologies, patient-centered...
press releasesRead more...
Vivodyne Launches the World’s Largest Human Biological Datacenter to Train the First World Model of Human Biology
Vivodyne the company making human biology computable at AI scale today announced the worlds largest human biological datacenter with robotic HIVE laboratories and the annual capacity to perform controlled
Novo Nordisk's Awiqli®, the first once-weekly basal insulin for adults with type 2 diabetes, now available in the US
Novo Nordisk today announced the nationwide launch of Awiqli insulin icodecabae injection unitsmL the first onceweekly basal insulin approved as an adjunct to diet and exercise
Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States
Arch Biopartners Inc TSX Venture ARCH and OTCQB ACHFF today announced that the Company will expand its ongoing Phase II trial of LSALT peptide targeting cardiac surgeryassociated acute kidney injury
Revolution Medicines and BeOne Medicines Announce Clinical Development and Regional Commercialization Collaboration
Revolution Medicines Inc a latestage clinical oncology company developing targeted therapies for patients with RASaddicted cancers and BeOne Medicines Ltd Nasdaq ONC HKEX SSE
Events Read more...
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
09 - 10
Sep 2026iPSC Drug Development Summit
Hyatt Regency Boston Harbour,...
LATEST NEWSRead more...
Avaí Bio and Austrianova Partner with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
Ava Bio and Austrianova have announced a research collaboration between their joint venture Insulinova and Ospedale San Raffaele OSR in Milan Italy to develop an encapsulated cell therapy for Type and insulindependent Type diabetes
Cycle Pharmaceuticals Selects Forma Life Sciences for US Commercial Supply of FDA-Approved CAVHANZA™ (nilotinib)
Cycle Pharmaceuticals has entered into a commercial manufacturing agreement with Forma Life Sciences to establish a US supply of CAVHANZA nilotinib orally disintegrating tablets
Abbott and Google Partner to Bring AI-Powered Glucose Insights to Everyday Health
Abbott has announced a multiyear partnership with Google Health to help people better understand their metabolic health by combining glucose insights from Abbotts Lingo biowearable with Googles artificial intelligence AI and consumer technology
Thermo Fisher Scientific and Michael J. Fox Foundation Expand Proteomics Research for Parkinson’s Precision Medicine
Thermo Fisher Scientific has completed Olink Explore HT proteomic analysis of around research samples from The Michael J Fox Foundations MJFF Parkinsons Precision Medicine Initiative PPMI
EIT Pharma Receives FDA Acceptance for Lonafarnib Application for Chronic Hepatitis D
EIT Pharma has announced that the US Food and Drug Administration FDA has accepted its New Drug Application NDA for lonafarnib for the treatment of chronic hepatitis D CHD
Spyre Therapeutics Launches SPY772 Programme and Begins Phase 2 Trial in Hidradenitis Suppurativa
Spyre Therapeutics has launched SPY a new combination programme designed to target two inflammatory pathways involved in immunemediated diseases The company has also started the Phase SKYLIGHT trial to assess the approach in patients with hidradenitis suppurativa HS
